Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib

Po-Shen KoDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ;School of Medicine, National Yang-Ming University, Taipei, Taiwan;

Yuan-Bin YuSchool of Medicine, National Yang-Ming University, Taipei, Taiwan; ;Division of Oncology and Hematology, Department of Internal Medicine, Far Eastern Memorial Hospital, Taipei, Taiwan;

Yao-Chung LiuDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ;School of Medicine, National Yang-Ming University, Taipei, Taiwan;

Yi-Tsui WuDepartment of Nursing, Taipei Veterans General Hospital, Taipei, Taiwan;

Man-Hsin HungSchool of Medicine, National Yang-Ming University, Taipei, Taiwan; ;Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan;

Jyh-Pyng GauDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ;School of Medicine, National Yang-Ming University, Taipei, Taiwan;

Chia-Jen LiuDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ;School of Medicine, National Yang-Ming University, Taipei, Taiwan; ;Institute of Public Health, National Yang-Ming University, Taipei, Taiwan;

Liang-Tsai HsiaoDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ;School of Medicine, National Yang-Ming University, Taipei, Taiwan;

Po-Min ChenDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ;School of Medicine, National Yang-Ming University, Taipei, Taiwan;

Tzeon-Jye ChiouSchool of Medicine, National Yang-Ming University, Taipei, Taiwan; ;Division of Transfusion Medicine, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;

Chun-Yu LiuSchool of Medicine, National Yang-Ming University, Taipei, Taiwan; ;Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan; Correspondence[email protected]

http://orcid.org/0000-0003-2336-4731

Jin-Hwang LiuDivision of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; ;Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei, Taiwan; ;Chong Hin Loon Memorial Cancer and Biotherapy Research Center, National Yang-Ming University, Taipei, Taiwan

show all

Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib

Supplemental_Table_4

Supplemental_Table_3

Supplemental_Table_2

Supplemental_Table_1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib

Supplemental_Table_4

Supplemental_Table_3

Supplemental_Table_2

Supplemental_Table_1

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date